Angus, Floro A.
HRN: 24-05-95 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/10/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/10/2023
11/16/2023
IVT
1.5g
Q6
Perianal Mass
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes